Literature DB >> 9592178

Increased expression of estrogen receptor beta in chemically transformed human breast epithelial cells.

Y F Hu1, K M Lau, S M Ho, J Russo.   

Abstract

Recent molecular cloning of estrogen receptor beta (ERbeta) suggests alternative pathways of estrogen signaling, but little is known concerning the role of ERbeta in the development of human breast cancer. In the present study, expression of ERalpha and ERbeta mRNA was determined in a series of chemically transformed human breast epithelial cells as well as various normal and malignant breast cancer cell lines. We observed a very low level of ERbeta expression in the mortal S130 and the spontaneously immortalized MCF10-F human breast epithelial cell lines. As MCF-10F cells were treated with environmental chemical carcinogens, an elevated level of ERbeta expression was observed in the resultant transformed BP1, D3 and BP1-ras cells. An even higher level of ERbeta expression was detected in the more transformed BP1-E, D3-1 and D3-1-ras cell lines. Therefore, results from our study indicate that expression of ERbeta can be induced in chemical carcinogen-transformed human breast epithelial cells, and the more transformed cells showed higher levels of ERbeta expression, regardless of which chemical carcinogens were initially used for cell transformation. These results suggest that expression of ERbeta may contribute to the initiation and progression of chemical carcinogen-induced neoplastic transformation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9592178     DOI: 10.3892/ijo.12.6.1225

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  11 in total

1.  Bisphenol A (BPA) Exposure In Utero Leads to Immunoregulatory Cytokine Dysregulation in the Mouse Mammary Gland: A Potential Mechanism Programming Breast Cancer Risk.

Authors:  Catha Fischer; Ramanaiah Mamillapalli; Laura G Goetz; Elisa Jorgenson; Ysabel Ilagan; Hugh S Taylor
Journal:  Horm Cancer       Date:  2016-02-24       Impact factor: 3.869

2.  Estrogen receptors and proliferation markers in primary and recurrent breast cancer.

Authors:  E V Jensen; G Cheng; C Palmieri; S Saji; S Mäkelä; S Van Noorden; T Wahlström; M Warner; R C Coombes; J A Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-04       Impact factor: 11.205

3.  Increased expression of histone proteins during estrogen-mediated cell proliferation.

Authors:  Zheying Zhu; Robert J Edwards; Alan R Boobis
Journal:  Environ Health Perspect       Date:  2009-02-07       Impact factor: 9.031

4.  Estradiol enhances sociosexual behavior and can have proliferative effects in ovariectomized rats.

Authors:  Alicia A Walf; Cheryl A Frye
Journal:  Age (Dordr)       Date:  2008-10-29

5.  [Pt(O,O'-acac)(gamma-acac)(DMS)], a new Pt compound exerting fast cytotoxicity in MCF-7 breast cancer cells via the mitochondrial apoptotic pathway.

Authors:  A Muscella; N Calabriso; F P Fanizzi; S A De Pascali; L Urso; A Ciccarese; D Migoni; S Marsigliante
Journal:  Br J Pharmacol       Date:  2007-11-19       Impact factor: 8.739

6.  Roles of estrogen receptor alpha and beta in modulating urothelial cell proliferation.

Authors:  Jian Teng; Zun-Yi Wang; David F Jarrard; Dale E Bjorling
Journal:  Endocr Relat Cancer       Date:  2008-03       Impact factor: 5.678

7.  Haplotypes of the estrogen receptor beta gene and breast cancer risk.

Authors:  David G Cox; Philip Bretsky; Peter Kraft; Paul Pharoah; Demetrius Albanes; David Altshuler; Pilar Amiano; Goran Berglund; Heiner Boeing; Julie Buring; Noel Burtt; Eugenia E Calle; Federico Canzian; Stephen Chanock; Françoise Clavel-Chapelon; Graham A Colditz; Heather Spencer Feigelson; Christopher A Haiman; Susan E Hankinson; Joel Hirschhorn; Brian E Henderson; Robert Hoover; David J Hunter; Rudolf Kaaks; Laurence Kolonel; Loic LeMarchand; Eiliv Lund; Domenico Palli; Petra H M Peeters; Malcolm C Pike; Elio Riboli; Daniel O Stram; Michael Thun; Anne Tjonneland; Ruth C Travis; Dimitrios Trichopoulos; Meredith Yeager
Journal:  Int J Cancer       Date:  2008-01-15       Impact factor: 7.396

Review 8.  ERalpha-negative and triple negative breast cancer: molecular features and potential therapeutic approaches.

Authors:  Jin-Qiang Chen; Jose Russo
Journal:  Biochim Biophys Acta       Date:  2009-06-13

9.  The estrogen receptor-alpha A908G (K303R) mutation occurs at a low frequency in invasive breast tumors: results from a population-based study.

Authors:  Kathleen Conway; Eloise Parrish; Sharon N Edmiston; Dawn Tolbert; Chiu-Kit Tse; Joseph Geradts; Chad A Livasy; Harsharan Singh; Beth Newman; Robert C Millikan
Journal:  Breast Cancer Res       Date:  2005-09-06       Impact factor: 6.466

10.  Risk factors for breast cancer characterized by the estrogen receptor alpha A908G (K303R) mutation.

Authors:  Kathleen Conway; Eloise Parrish; Sharon N Edmiston; Dawn Tolbert; Chiu-Kit Tse; Patricia Moorman; Beth Newman; Robert C Millikan
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.